CA 125: a misleading tumor marker?
Schrijvers
D
D
Department of Medical Oncology, University Hospital of Antwerp, Edegem, Belgium.
van Dam
P
P
van Oosterom
A
A
D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D018394:CA-125 Antigen / Q000097:blood*; D018282:Cystadenocarcinoma, Mucinous / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D000077143:Docetaxel; D005260:Female; D006801:Humans; D008207:Lymphatic Metastasis; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000097:blood* / Q000188:drug therapy / Q000473:pathology; D017239:Paclitaxel / Q000031:analogs & derivatives / Q000627:therapeutic use; D010534:Peritoneal Neoplasms / Q000556:secondary; D043823:Taxoids
D000972:Antineoplastic Agents, Phytogenic; D018394:CA-125 Antigen; D043823:Taxoids; D000077143:Docetaxel; D017239:Paclitaxel